Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 5/20 | 0.49 |
| ▸ | CSNK1G2 | P78368 | 4/20 | 0.49 |
| ▸ | KIF11 | P52732 | 4/20 | 0.49 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | G6PD | P11413 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | CCR9 | P51686 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11633530 | 0.84 | CSNK1D (0.45) | CSNK1DCSNK1G2KIF11CSNK1A1GSK3B | |
| SCHEMBL549183 | 0.84 | G6PD (0.45) | G6PDDYRK1AMIFAPP | |
| SCHEMBL2706410 | 0.84 | ALDH1A1 (0.43) | KIF11L3MBTL1 | |
| SCHEMBL19735281 | 0.83 | CSNK1D (0.49) | CSNK1DCSNK1G2KIF11CSNK1A1GSK3B | |
| SCHEMBL26179241 | 0.80 | KIF11 (0.34) | CSNK1DCSNK1G2KIF11 | |
| SCHEMBL24617032 | 0.78 | CSNK1D (0.37) | CSNK1DCSNK1G2KIF11G6PDDYRK1A | |
| SCHEMBL24617565 | 0.78 | KIF11 (0.41) | CSNK1DCSNK1G2KIF11CSNK1A1GSK3B | |
| SCHEMBL18347531 | 0.77 | ALDH1A1 (0.48) | CSNK1DCSNK1G2CSNK1A1GSK3BG6PD | |
| SCHEMBL24604645 | 0.77 | KIF11 (0.42) | KIF11L3MBTL1 | |
| SCHEMBL25582011 | 0.76 | KIF11 (0.52) | CSNK1DCSNK1G2KIF11CSNK1A1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | CNOT1, NXF1, NR2E1 | CSNK1D 1238/4885CSNK1G2 468/4885KIF11 4420/4885 |
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | EXOC4, CYBA, SCO2 | CSNK1D 2537/4885CSNK1G2 2692/4885KIF11 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.